To further validate this hypothesis, we examined patient‐derived, paraffin‐embedded breast cancer tissue sections by immunohistochemistry, using both the AGO1x antibody and an antibody for the proliferation marker Ki‐67 (Li et al, 2015). Here, MKI67 is linked to breast cancer.